A recent study also indicated that the activation of the epidermal growth factor (EGF)-EGF receptor signaling pathway is associated with the development of CK19 (+) HCC, and this pathway may account for the poor prognosis of patients[35]. The gene discussed is KRT19; the disease is hepatocellular carcinoma.